Dose reduction of ibrutinib in chronic lymphocytic leukemia: long-term outcomes from a real-world single-center experience. (2026). Mediterranean Journal of Hematology and Infectious Diseases, 18(1), e2026090. https://doi.org/10.4084/MJHID.2026.090